-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Approaches for Relapsed CLL After Chemotherapy-Free Frontline Regimens

Program: Education Program
Session: A Map for the Changing Landscape of CLL
Hematology Disease Topics & Pathways:
Biological, antibodies, Diseases, Therapies, Non-Hodgkin Lymphoma, immunotherapy, Lymphoid Malignancies, Clinically relevant
Saturday, December 5, 2020, 7:25 AM-7:30 AM

Anthony R. Mato, MD

Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Mato: Adaptive: Consultancy, Research Funding; AstraZeneca: Consultancy, Research Funding; LOXO: Consultancy, Research Funding; BeiGene: Consultancy; Pharmacyclics LLC, an AbbVie Company: Consultancy, Research Funding; AbbVie: Consultancy, Research Funding; TG Therapeutics: Consultancy, Other: DSMB, Research Funding; Genentech: Consultancy, Research Funding; Janssen: Consultancy, Research Funding.

<< Previous Presentation | Next Presentation